Skip to main content

Advertisement

SpringerLink
Log in

Matrix metalloproteinase-2 promoter variability in psoriasis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

The expression of matrix metalloproteinase-2 was observed to be significantly upregulated in psoriasis. The aim of this study was to associate the DNA polymorphic variants in MMP-2 promoter gene with psoriasis and/or with psoriasis phenotypes related to psoriasis and comorbid heredity. In the total of 582 Czech Caucasian individuals (386 patients with psoriasis and 196 controls of similar age and sex distribution without personal or family history of chronic disease of the skin), four MMP-2 promoter polymorphisms (−1575G/A, −1306C/T, −790T/G and −735C/T) were detected by PCR methods. A significant association of GG genotype of −790 MMP-2 polymorphism with psoriasis was observed (Pcorr = 0.04). Although no significant case–control differences in frequency of associated GG(−1575)CC(−1306)TT(−790) MMP-2 promoter genotype were observed, the genotype was found to be significantly less frequent in patients with family history of psoriasis (close as well as distant), family history of diabetes and personal history of allergy (2/11 vs. 55/32, odds ratio (OR) for GGCCTT 0.11, 95% confidential interval 0.02–0.50, Pcorr = 0.01). The significant difference between psoriatic patients with positive anamnestic data on diabetes, psoriasis and allergy compared with psoriatic patients that have only positive family history of diabetes was also observed (2/11 vs. 38/31, P = 0.009, Pcorr = 0.04; OR 0.15, 95% CI = 0.03–0.72 for psoriatic patients with GGCCTT genotype and family history of psoriasis, diabetes and personal history of allergy). To conclude, the associated GGCCTT genotype in the promoter of MMP-2 gene was less frequent in patients with positive family history of psoriasis, diabetes and personal history of allergy compared with psoriatic patients without them (2/11 vs. 68/57, P = 0.007, Pcorr = 0.04; OR = 0.15, 95% CI = 0.03–0.72 for psoriatic patients with family history of psoriasis and diabetes and with allergy). Based on our results, we suggest that the MMP-2 located in the psoriasis susceptibility region on 16q (psoriasis susceptibility 8, PSORS8) should be considered as a gene modulator of psoriasis in specific subgroups of patients. In the future, similar genetic characteristics could contribute to the data assembly of genetic predisposition to psoriasis and could lead to therapy improvement based on time-proved individual pharmacogenetic aspects detected in psoriasis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beránek M, Kolar P, Tschoplova S et al (2008) Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Mol Vis 14:1114–1121

    PubMed  Google Scholar 

  2. Borgiani P, Vallo L, D’Apice MR et al (2002) Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol 12:540–542

    PubMed  CAS  Google Scholar 

  3. Chen M, Chen ZQ, Cui PG et al (2008) The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br J Dermatol 158:987–993. doi:10.1111/j.1365-2133.2008.08505.x

    Article  PubMed  CAS  Google Scholar 

  4. Chen M, Cui PG, Yao X et al (2007) The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:674–676

    PubMed  CAS  Google Scholar 

  5. Christophers E (2007) Comorbidities in psoriasis. Clin Dermatol 25:529–534. doi:10.1016/j.clindermatol.2007.08.006

    Article  PubMed  Google Scholar 

  6. Cordiali-Fei P, Trento E, D’Agosto G et al (2007) Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions. Ann NY Acad Sci 1110:578–589. doi:10.1196/annals.1423.062

    Article  PubMed  CAS  Google Scholar 

  7. Deniaud E, Baguet J, Mathieu AL et al (2006) Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25:7096–7105. doi:10.1038/sj.onc.1209696

    Article  PubMed  CAS  Google Scholar 

  8. Derosa G, Ferrari I, D’Angelo A et al (2008) Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium 15:219–224. doi:10.1080/10623320802228815

    Article  PubMed  CAS  Google Scholar 

  9. Fatar M, Stroick M, Steffens M et al (2008) Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes. Cerebrovasc Dis 26:113–119. doi:10.1159/000139657

    Article  PubMed  CAS  Google Scholar 

  10. Fleischmajer R, Kuroda K, Hazan R et al (2000) Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. J Invest Dermatol 115:771–777. doi:10.1046/j.1523-1747.2000.00138.x

    Article  PubMed  CAS  Google Scholar 

  11. Fuchs O (2006) EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases. Cas Lek Cesk 145:619–624

    PubMed  CAS  Google Scholar 

  12. Głowińska-Olszewska B, Urban M, Florys B (2006) Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 12:179–183

    PubMed  Google Scholar 

  13. Han YP, Tuan TL, Wu H et al (2001) TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 114:131–139

    PubMed  CAS  Google Scholar 

  14. Harendza S, Lovett DH, Panzer U et al (2003) Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem 278:20490–20499. doi:10.1074/jbc.M211536200

    Article  PubMed  CAS  Google Scholar 

  15. Holla LI, Fassmann A, Vasku A et al (2005) Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis. J Periodontol 76:1056–1060. doi:10.1902/jop.2005.76.7.1056

    Article  PubMed  CAS  Google Scholar 

  16. International Psoriasis Genetics Consortium (2003) The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet 73:430–437. doi:10.1086/377159

    Article  Google Scholar 

  17. Jakobsson L, Claesson-Welsh L (2008) Vascular basement membrane components in angiogenesis—an act of balance. ScientificWorldJournal 8:1246–1249. doi:10.1100/tsw.2008.155

    Article  PubMed  CAS  Google Scholar 

  18. Langers AM, Sier CF, Hawinkels LJ et al (2008) MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. Br J Cancer 98:1820–1823. doi:10.1038/sj.bjc.6604380

    Article  PubMed  CAS  Google Scholar 

  19. Mark EB, Jonsson M, Asp J et al (2006) Expression of genes involved in the regulation of p16 in psoriatic involved skin. Arch Dermatol Res 297:459–467. doi:10.1007/s00403-006-0649-1

    Article  PubMed  CAS  Google Scholar 

  20. Mastroianni A, Minutilli E, Mussi A et al (2005) Cytokine profiles during infliximab monotherapy in psoriatic arthritis. Br J Dermatol 153:531–536. doi:10.1111/j.1365-2133.2005.06648.x

    Article  PubMed  CAS  Google Scholar 

  21. Miksztowicz V, Muzzio ML, Royer M et al (2008) Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome. Metabolism 57:1493–1496. doi:10.1016/j.metabol.2008.06.001

    Article  PubMed  CAS  Google Scholar 

  22. Nair RP, Henseler T, Jenisch S et al (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6:1349–1356. doi:10.1093/hmg/6.8.1349

    Article  PubMed  CAS  Google Scholar 

  23. Nair RP, Stuart P, Henseler T et al (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66:1833–1844. doi:10.1086/302932

    Article  PubMed  CAS  Google Scholar 

  24. Nair RP, Stuart P, Ogura Y et al (2001) Lack of association between NOD2 3020insC frameshift mutation and psoriasis. J Invest Dermatol 117:1671–1672. doi:10.1046/j.0022-202x.2001.01620.x

    Article  PubMed  CAS  Google Scholar 

  25. Nemec P, Goldbergová M, Swobodnik T et al (2006) Polymorphism of gene promoter region for MMP-2 in rheumatoid arthritis. Vnitr Lek 52:348–354

    PubMed  CAS  Google Scholar 

  26. Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558. doi:10.1074/jbc.M010242200

    Article  PubMed  CAS  Google Scholar 

  27. Rahman P, Bartlett S, Siannis F et al (2003) CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 73:677–681. doi:10.1086/378076

    Article  PubMed  CAS  Google Scholar 

  28. Segre JA, Bauer C, Fuchs E (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22:356–360. doi:10.1038/11926

    Article  PubMed  CAS  Google Scholar 

  29. Shahabi S, Hassan ZM, Jazani NH et al (2006) Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67:900–903. doi:10.1016/j.mehy.2006.03.039

    Article  PubMed  CAS  Google Scholar 

  30. Simonetti O, Lucarini G, Goteri G et al (2006) VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study. Int J Immunopathol Pharmacol 19:751–760

    PubMed  CAS  Google Scholar 

  31. Sipetić S, Vlajinac H, Kocev N et al (2002) Family history and risk of type 1 diabetes mellitus. Acta Diabetol 39:111. doi:10.1007/s005920200028

    Article  PubMed  Google Scholar 

  32. Vasku A, Goldbergová M, Izakovicová Hollá L et al (2004) A haplotype constituted of four MMP-2 promoter polymorphisms (−1575G/A, −1306C/T, −790T/G and −735C/T) is associated with coronary triple-vessel disease. Matrix Biol 22:585–591. doi:10.1016/j.matbio.2003.10.004

    Article  PubMed  CAS  Google Scholar 

  33. Vasku V, Vasku A, Tschöplová S et al (2002) Genotype association of C(−735)T polymorphism in matrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis. Dermatology 204:262–265. doi:10.1159/000063355

    Article  PubMed  CAS  Google Scholar 

  34. Wang CH, Chang HC, Hung WC (2006) p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription. J Cell Physiol 208:246–252. doi:10.1002/jcp.20660

    Article  PubMed  CAS  Google Scholar 

  35. Xue M, Jackson CJ (2008) Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes. J Invest Dermatol 128:2676–2685. doi:10.1038/jid.2008.136

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1st Department of Dermatology, Faculty of Medicine, St. Ann’s Faculty Hospital, Masaryk University Brno, Pekařská 53, 656 91, Brno, Czech Republic

    Vladimir Vasku & Veronika Slonková

  2. Department of Pathophysiology, Faculty of Medicine, Masaryk University, University Campus Bohunice, A18, Kamenice 5, 625 00, Brno, Czech Republic

    Julie Bienertova Vasku, Kateřina Kaňková & Anna Vasku

Authors
  1. Vladimir Vasku
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Bienertova Vasku
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Veronika Slonková
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kateřina Kaňková
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Vasku
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimir Vasku.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasku, V., Bienertova Vasku, J., Slonková, V. et al. Matrix metalloproteinase-2 promoter variability in psoriasis. Arch Dermatol Res 301, 467–473 (2009). https://doi.org/10.1007/s00403-009-0947-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0947-5

Keywords

Search

Navigation